Triple #20274

high Confidence

Knowledge triple

imatinib_mesylate

Targeted drugs

Level 11

induces

Positive regulatory relationship

partial_response_with_tumor_size_reduction

Response to treatment

Level 12

Original triple: Neoadjuvant imatinib mesylate treatment#revealed#a partial response with tumor size reduction

Evidence and Confidence

Confidence: high
Evidence Strength: clinical
Condition Dependency: preoperative
Fact or Inference: Fact

Clinical Relevance

Clinical Relevance: Response to treatment

Other Info

PMID: 21191613
Knowledge Particle: KP11
Value Leadboard: -
Disease: Tumor
Treatment: Imatinib mesylate